SCHEMBL6863707

SCHEMBL6863707

CCCCCCCCC(CC(=O)OCC(C)(C)C)C(=O)OCC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.42
GPR84 Q9NQS5 7/20 0.41
FFAR1 O14842 1/20 0.41
BIRC2 Q13490 2/20 0.40
ZDHHC7 Q9NXF8 1/20 0.40
CA1 P00915 1/20 0.39
GRIK1 P39086 1/20 0.38
GRIK2 Q13002 1/20 0.38
USP2 O75604 1/20 0.38
LMNA P02545 1/20 0.38
NAAA Q02083 1/20 0.37
DGKA P23743 1/20 0.37
MMP2 P08253 3/20 0.37
MMP3 P08254 3/20 0.37
MMP1 P03956 2/20 0.37
MMP7 P09237 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2455229 1.00 CA2 (0.42) CA2GPR84FFAR1BIRC2ZDHHC7
SCHEMBL6872021 1.00 CA2 (0.42) CA2GPR84FFAR1BIRC2ZDHHC7
SCHEMBL6874422 1.00 CA2 (0.42) CA2GPR84FFAR1BIRC2ZDHHC7
SCHEMBL6867875 1.00 CA2 (0.42) CA2GPR84FFAR1BIRC2ZDHHC7
SCHEMBL6873367 1.00 CA2 (0.42) CA2GPR84FFAR1BIRC2ZDHHC7
SCHEMBL6868358 1.00 CA2 (0.42) CA2GPR84FFAR1BIRC2ZDHHC7
SCHEMBL11042177 1.00 CA2 (0.42) CA2GPR84FFAR1BIRC2ZDHHC7
SCHEMBL6873192 1.00 CA2 (0.42) CA2GPR84FFAR1BIRC2ZDHHC7
SCHEMBL6868202 0.98 BIRC2 (0.41) CA2GPR84FFAR1BIRC2ZDHHC7
SCHEMBL6863975 0.93 CA2 (0.44) CA2BIRC2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165633-B1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE SPA (IT) 2004-07-14 EP claimed
US-6716939-B2 COMPRISING TITANIUM, MAGNESIUM, HALOGEN AND AN ELECTRON DONOR COMPOUND SELECTED FROM ESTERS OF SUBSTITUTED SUCCINIC ACIDS BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2004-04-06 US claimed
US-20020183575-A1 Components and catalysts for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2002-12-05 US claimed
EP-1165633-B1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE SPA (IT) 2004-07-14 EP disclosed
US-6716939-B2 COMPRISING TITANIUM, MAGNESIUM, HALOGEN AND AN ELECTRON DONOR COMPOUND SELECTED FROM ESTERS OF SUBSTITUTED SUCCINIC ACIDS BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2004-04-06 US disclosed
US-20020183575-A1 Components and catalysts for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2002-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183575-A1 Components and catalysts for the polymerization of olefins SCO2, ECI1, MT-CO2 CA2 1406/4885GPR84 2603/4885FFAR1 1768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.